what bmi qualifies for glp 1 Pediatric obesity management algorithm. BMI, body mass index; GLP1, Do you qualify for GLP-1

For example, liraglutide (LEADER trial), injectable semaglutide (SUSTAIN-6), dulaglutide (REWIND), and high-dose semaglutide (SELECT) have shown cardiovascular risk reduction in their respective clinical trials

Roche Holding AG Sanofi S.A

In people with overweight/obesity and non-diabetic CKD who were included in the SMART study, 2.4 mg semaglutide once weekly versus placebo reduced UACR by 52% at 24 weeks of treatment (87)

Reducing from 1 mg to 0.5 mg, or from 2 mg to 1 mg, is a perfectly valid approach

Iatcu OC, et al

Join 275,000+ subscribers and keep yourself informed with a selection of The Weeks most interesting, enlightening, and entertaining stories - plus daily puzzles.